1. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Weekly Rep. 2008;57:1–30 (quiz CE2–4. Epub 2008/06/06 PubMed PMID: 18528318).
2. Saguil A, Kane S, Mercado M, et al. Herpes zoster and postherpetic neuralgia: prevention and management. Am Fam Physician. 2017;96(10):656–63 (Epub 2018/02/13 PubMed PMID: 29431387).
3. Lu PJ, O’Halloran A, Williams WW, et al. National and state-specific shingles vaccination among adults aged >/=60 years. Am J Prev Med. 2017;52(3):362–72.
https://doi.org/10.1016/j.amepre.2016.08.031
(Epub 2016/10/11. PubMed PMID: 27720342; PubMed Central PMCID: PMCPMC5818280).
4. Williams DR, Mohammed SA. Discrimination and racial disparities in health: evidence and needed research. J Behav Med. 2009;32(1):20–47.
https://doi.org/10.1007/s10865-008-9185-0
(Epub 2008/11/26. PubMed PMID: 19030981; PubMed Central PMCID: PMCPMC2821669).
5. Shingrix (Zoster Vaccine Recombinant, Adjuvanted). GlaxoSmithKline Biologicals, Rixensart, Belgium; 2017.
https://gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF
. Accessed 27 Sept 2019.